The Challenge of Offering Long-Acting Antipsychotic Therapies

Journal of Clinical Psychiatry - United States
doi 10.4088/jcp.13m08946
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Physicians Postgraduate Press, Inc

Related search

PMH84 Validity of Administrative Claims Data for Calculating Adherence Measures for Long-Acting Injectable (Lai) Antipsychotic Therapies

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

The Long-Acting Integrase Inhibitor GSK744 Protects Macaques From Repeated Intravaginal SHIV Challenge

Science Translational Medicine
Medicine
2015English

An Unusual Complication of a Long-Acting Injectable Antipsychotic: Deep Venous Thrombosis Caused by Olanzapine Pamoate

Psychiatry and Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2017English

Evaluation of Paliperidone Palmitate Long‐acting Injectable Antipsychotic Therapy as an Early Treatment Option in Patients With Schizophrenia

Early Intervention in Psychiatry
PsychiatryMental HealthPsychiatric Mental HealthBiological Psychiatry
2019English

The Challenge of Herbal Therapies for Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Long-Run Underperformance and the Offering Price Clustering Phenomenon

Journal of Business & Economics Research (JBER)
2010English

Administration of a Long-Acting Antipsychotic Injection to a Child While Managing Contraindicated Polypharmacy Interactions and Transition Between Services

BMJ Case Reports
Medicine
2019English

The Challenge of Developing New Therapies for Childhood Cancers

Oncologist
Cancer ResearchMedicineOncology
1997English

Long-Acting Methods of Contraception

New England Journal of Medicine
Medicine
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy